Found: 19
Select item for more details and to access through your institution.
Modulation of cyclic AMP levels and differentiation by adenosine analogs in mouse erythroleukemia cells.
- Published in:
- Journal of Cellular Physiology, 1988, v. 134, n. 3, p. 429, doi. 10.1002/jcp.1041340314
- By:
- Publication type:
- Article
Biological Consequences of Gene Regulation After Ionizing Radiation Exposure.
- Published in:
- JNCI: Journal of the National Cancer Institute, 1991, v. 83, n. 7, p. 480
- By:
- Publication type:
- Article
Recombinant Human Tumor Necrosis Factor Administered as a 24-Hour Intravenous Infusion. A Phase I and Pharmacologic Study2.
- Published in:
- JNCI: Journal of the National Cancer Institute, 1988, v. 80, n. 13, p. 1039
- By:
- Publication type:
- Article
Sotatercept (ACE-011) for the treatment of chemotherapy-induced anemia in patients with metastatic breast cancer or advanced or metastatic solid tumors treated with platinum-based chemotherapeutic regimens: results from two phase 2 studies.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Single-Dose, Randomized, Double-Blind, Placebo-Controlled Study of ACE-011 (ActRIIA-IgG1) in Postmenopausal Women.
- Published in:
- Journal of Bone & Mineral Research, 2009, v. 24, n. 4, p. 744, doi. 10.1359/jbmr.081208
- By:
- Publication type:
- Article
Sotatercept in patients with osteolytic lesions of multiple myeloma.
- Published in:
- British Journal of Haematology, 2014, v. 165, n. 6, p. 814, doi. 10.1111/bjh.12835
- By:
- Publication type:
- Article
Locally acting ACE-083 increases muscle volume in healthy volunteers.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Myostatin inhibitor ACE-031 treatment of ambulatory boys with Duchenne muscular dystrophy: Results of a randomized, placebo-controlled clinical trial.
- Published in:
- 2017
- By:
- Publication type:
- journal article
A single ascending-dose study of muscle regulator ace-031 in healthy volunteers.
- Published in:
- Muscle & Nerve, 2013, v. 47, n. 3, p. 416, doi. 10.1002/mus.23539
- By:
- Publication type:
- Article
The Role for Interleukin-12 Therapy of Cutaneous T Cell Lymphoma.
- Published in:
- Annals of the New York Academy of Sciences, 2001, v. 941, n. 1, p. 177, doi. 10.1111/j.1749-6632.2001.tb03721.x
- By:
- Publication type:
- Article
A phase 2 study of the cytotoxic immunoconjugate CMB-401 (hCTM01-calicheamicin) in patients with platinum-sensitive recurrent epithelial ovarian carcinoma.
- Published in:
- Cancer Immunology, Immunotherapy, 2003, v. 52, n. 4, p. 243, doi. 10.1007/s00262-002-0343-x
- By:
- Publication type:
- Article
Final report of the efficacy and safety of gemtuzumab ozogamicin (Mylotarg) in patients with CD33-positive acute myeloid leukemia in first recurrence.
- Published in:
- 2005
- By:
- Publication type:
- journal article
Final report of the efficacy and safety of gemtuzumab ozogamicin (Mylotarg) in patients with CD33‐positive acute myeloid leukemia in first recurrence.
- Published in:
- Cancer (0008543X), 2005, v. 104, n. 7, p. 1442, doi. 10.1002/cncr.21326
- By:
- Publication type:
- Article
Multiple-dose, safety, pharmacokinetic, and pharmacodynamic study of sotatercept (ActRIIA-IgG1), a novel erythropoietic agent, in healthy postmenopausal women.
- Published in:
- Journal of Clinical Pharmacology, 2013, v. 53, n. 11, p. 1121, doi. 10.1002/jcph.160
- By:
- Publication type:
- Article
A phase 1 study of ACE-536, a regulator of erythroid differentiation, in healthy volunteers.
- Published in:
- American Journal of Hematology, 2014, v. 89, n. 7, p. 766, doi. 10.1002/ajh.23732
- By:
- Publication type:
- Article
A phase 2, randomized trial evaluating the combination of dalantercept plus axitinib in patients with advanced clear cell renal cell carcinoma.
- Published in:
- 2019
- By:
- Publication type:
- journal article
A phase 2 study of dalantercept, an activin receptor-like kinase-1 ligand trap, in patients with recurrent or metastatic squamous cell carcinoma of the head and neck.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Clinical Benefit of Ripretinib Dose Escalation After Disease Progression in Advanced Gastrointestinal Stromal Tumor: An Analysis of the INVICTUS Study.
- Published in:
- Oncologist, 2021, v. 26, n. 11, p. e2053, doi. 10.1002/onco.13917
- By:
- Publication type:
- Article
A Phase Ib, Open‐Label Study of Dalantercept, an Activin Receptor‐Like Kinase 1 Ligand Trap, plus Sorafenib in Advanced Hepatocellular Carcinoma.
- Published in:
- Oncologist, 2019, v. 24, n. 2, p. 161, doi. 10.1634/theoncologist.2018-0654
- By:
- Publication type:
- Article